Affimed Nv logo

Affimed Nv Share Price Today (NASDAQ: AFMD)

Affimed Nv share price is $0.18 & ₹15.49 as on 15 May 2025 IST

$0.18

-0.1

(-35.71%)

Market is closed - opens 7 PM, 16 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 16 May 2025

View live Affimed Nv share price in Dollar and Rupees. Guide to invest in Affimed Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Affimed Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Affimed Nv (AFMD) Key Statistics

in dollars & INR

Previous Close
$0.28
Open
$0.211
Market Capitalization
$4.6M
Today's Volume
$23.1M
Revenue TTM
$5.6M
EBITDA
$-60.8M
Earnings Per Share (EPS)
$-5.09
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-149.49%

How to invest in Affimed Nv Stock (AFMD) from India?

It is very easy for Indian residents to invest directly in Affimed Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Affimed Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Affimed Nv or AFMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Affimed Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Affimed Nv shares which would translate to 4.781 fractional shares of Affimed Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Affimed Nv, in just a few clicks!

Indian investors sentiment towards Affimed Nv (AFMD)

526.98%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Investment in Affimed Nv Shares from India has grown by 526.98% over the past 30 days, indicating increased transactional activity.

Global Institutional Holdings in Affimed Nv

  • 683 Capital Management LLC

    3.99%

  • NEA Management Company, LLC

    2.70%

  • Point72 Asset Management, L.P.

    2.09%

  • Northern Trust Corp

    1.12%

  • TANG CAPITAL MANAGEMENT LLC

    0.90%

  • Vanguard Group Inc

    0.79%

Analyst Recommendation on Affimed Nv

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Affimed Nv(by analysts ranked 0 to 5 stars)

AFMD Affimed Nv Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY18
FY19
FY20
FY21
FY22
FY23
FY23Y/Y Change
Revenue
$9.0M
↓ 79.99%
Net Income
$-115.6M
↑ 23.18%
Net Profit Margin
-1.3K%
↓ 1072.24%

About Affimed Nv

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. The company's lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development for the treatment acute myeloid. It develops AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. It has collaboration with Artiva Biotherapeutics to develop the combination of acimtamig and AlloNK; license and strategic collaboration agreement with Roivant Sciences Ltd. to develop and commercialize novel ICE molecules, including AFM32, in oncology; and strategic collaboration agreement with Genentech for the development of certain product candidates, which includes novel NK cell engager-based immunotherapeutics to treat multiple cancers. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Mannheim, Germany.
Organization
Affimed Nv
Employees
76
CEO
Dr. Shawn M. Leland Pharm.D., R.Ph.
Industry
Health Technology

Management People of Affimed Nv

NameTitle
Dr. Wolfgang Fischer Ph.D.
MD, COO, Chief Strategy Officer & Member of Management Board
Ms. Denise Mueller
Chief Business Officer & Member of Management Board
Dr. Andreas Harstrick M.D.
Chief Medical Officer & Member of Management Board
Dr. Shawn M. Leland Pharm.D., R.Ph.
Chief Executive Officer
Prof. Melvyn Little
Founder & Consultant
Mr. Michael Wolf
Head of Finance & Administration
Mr. Alexander Fudukidis
Head of Investor Relations & Director of Investor Relations
Mary Beth Sandin
Vice President of Marketing & Communications

Important FAQs about investing in AFMD Stock from India :

Can Indians buy Affimed Nv shares?

Yes, Indians can invest in the Affimed Nv (AFMD) from India.

With INDmoney, you can buy Affimed Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Affimed Nv at zero transaction cost.

How can I buy Affimed Nv shares from India?

It is very easy to buy Affimed Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Affimed Nv (AFMD) be purchased?

Yes, you can buy fractional shares of Affimed Nv with INDmoney app.

What are the documents required to start investing in Affimed Nv stocks?

To start investing in Affimed Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Affimed Nv?

Today's market capitalisation of Affimed Nv AFMD is 4.6M

Who is the Chief Executive Officer (CEO) of Affimed Nv ?

Dr. Shawn M. Leland Pharm.D., R.Ph. is the current Chief Executive Officer (CEO) of Affimed Nv.